| Description | DNMT3A Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components DNMT3A siRNA-1: 5 nmol (HPLC) DNMT3A siRNA-2: 5 nmol (HPLC) DNMT3A siRNA-3: 5 nmol (HPLC) siRNA Negative DNMT3A Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components DNMT3A siRNA-1: 5 nmol (HPLC) DNMT3A siRNA-2: 5 nmol (HPLC) DNMT3A siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination... Read More | p53 and MDM2 proteins-interaction-inhibitor (chiral) (Compound 32) is an inhibitor of the interaction between p53 and MDM2 proteins | Inquire | purity>97% by SDS-PAGE and HPLC analysesFunctionFunctionElicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.Post-translationalMay possess two intramolecular disulfide bonds |